Published in the journal, Lancet Neurology, a new study suggests that understanding stroke severity, as well as time to treatment, is key to delivering effective and safe thrombolysis treatment.
A panel of independent experts has decided that alteplase, a clot-busting drug often used to treat strokes is safe and effective under current guidelines.
This research will produce an assessment of functional, everyday reading. The assessment will help therapists working with people with aphasia to identify why the person is finding it difficult to read and monitor the effects of treatment.
The International Stroke Conference (ISC) 2018 took place in Los Angeles (24-26 January).
The ISC is the world's largest meeting dedicated to the science and treatment of stroke and its effects. Check out some of the highlights from 2018.
On February 11, at the International Stroke Conference (ISC 2015 in Nashville, USA) the latest findings were released from four, large studies investigating the effect of treating patients with mechanical clot retrieval.
These summaries of our completed research projects highlight what work was undertaken, which aims were achieved and where the research is going next.
The International Stroke Conference is taking place in Los Angeles next week (24-26 January 2018).
It is the world's largest meeting dedicated to the science and treatment of stroke and its effects.
As well as exciting stroke research, the conference will also present the latest in international development and stroke.
Co-funded by the Stroke Association, a new review of the research into NIBS (non-invasive brain stimulation) for the recovery of leg movement and walking suggests that although it can bring about changes in leg function, the design of existing studies are very different, making it difficult to determine its effectiveness.
This study will show whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful, the study will pave the way for the design a larger definitive trial.
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.